Browse the evidence

Dumbbell and cable lateral raises produce equivalent lateral deltoid hypertrophy when shoulder abduction/adduction range of motion is standardized and matched between conditions.

You can use either dumbbells or cables for lateral raises to build your side delts. The key is to match the range of motion (lifting your arm to about 90 degrees) and train to failure for 5 sets, twice a week. Don't worry about which machine is 'better' mechanically; just pick the one you prefer and stick with it.

High-intensity interval training (HIIT) engages a unique subset of skeletal muscle signaling pathways and substrates compared to work- and duration-matched moderate-intensity continuous training (MICT), specifically involving kinases like PKC alpha/beta and substrates like MTFP1, which are associated with plasma lactate levels.

To trigger unique muscle adaptations associated with high-intensity training, you don't need to exercise for hours. A short session of 5 minutes of high-intensity intervals (e.g., 1-minute sprints followed by 1-minute recovery, repeated 5 times) is sufficient to activate specific signaling pathways (like PKC and MTFP1) that are not significantly engaged by moderate, continuous exercise of the same total duration and workload. This suggests HIIT is a highly time-efficient strategy for stimulating metabolic and mitochondrial adaptations.

Front-of-pack labeling (FOPL) and sugar-sweetened beverage (SSB) taxes are cost-effective population-level primary prevention strategies that reduce consumption, though their effectiveness varies by socioeconomic status and literacy.

Support policies like sugar taxes and clear food labeling. These are proven to reduce sugary drink consumption and encourage companies to make healthier products. While they may not solve obesity alone, they are a cost-effective way to improve population health.

Bariatric surgery provides superior, durable weight loss and metabolic improvement compared to non-surgical interventions, including pharmacotherapy.

If you have severe obesity (BMI ≥40, or ≥35 with health issues) and lifestyle changes haven't worked, bariatric surgery is the most effective long-term solution for weight loss and metabolic health. While it has higher upfront costs and risks, it is more cost-effective over time than lifelong medication. Consult a specialist to see if you qualify.

Metformin, alpha-lipoic acid (ALA), and GLP-1 receptor agonists are effective, complementary pharmacological interventions for managing metabolic syndrome, with metformin serving as the universal first-line treatment due to its safety, low cost, and wide availability.

For patients with Metabolic Syndrome, especially in crisis or resource-limited settings, start with metformin as the primary treatment due to its proven safety, low cost, and wide availability. Add alpha-lipoic acid (ALA) to target oxidative stress and insulin sensitivity, and consider GLP-1 agonists if cardiovascular risk is high and resources allow. Simplify regimens and use telemedicine to support adherence, as stress and disruption are major barriers to care.

The MicroSimulation Core Obesity Model (MS-COM) accurately predicts cardiovascular and mortality outcomes in adults with overweight or obesity, including those with normoglycemia, prediabetes, or type 2 diabetes, supporting its use for evaluating obesity management interventions.

For policymakers and health technology assessment bodies, the MS-COM model provides a reliable tool to evaluate the cost-effectiveness of obesity interventions (like semaglutide 2.4 mg) by accurately predicting long-term cardiovascular and mortality risks in overweight and obese adults, including those with diabetes.

Bariatric surgery (gastric banding, bypass, sleeve gastrectomy) results in large weight loss, induces remission of type-2 diabetes and hypertension, and increases life expectancy.

For severe obesity where other methods fail, bariatric surgery is a highly effective option that can lead to significant weight loss and remission of conditions like diabetes and high blood pressure. It can also increase life expectancy and be cost-effective over the long term, provided resources are available.

Preoperative Total Abdominal Fat Area (TAFA) is an independent predictor of excellent weight loss outcomes following laparoscopic sleeve gastrectomy, with lower TAFA predicting higher likelihood of achieving >75% excess weight loss and >30% total weight loss.

If you are considering sleeve gastrectomy, ask your surgeon about measuring your abdominal fat area (via CT or MRI) before surgery. A lower abdominal fat area is associated with a significantly higher chance of achieving excellent weight loss results. This metric offers more predictive power than BMI alone.

Tirzepatide treatment for obesity is associated with a very low incidence of macronutrient malnutrition and vitamin deficiency adverse events, with fewer than 1% of patients discontinuing treatment due to nutritional status concerns.

If you are taking tirzepatide for obesity, the risk of developing serious nutritional deficiencies or malnutrition is very low, especially if you follow the recommended dietary counseling. The study showed that fewer than 1% of patients had adverse events related to malnutrition. To stay healthy, focus on the recommended diet (high protein, balanced macros) and attend your lifestyle counseling sessions.

Resistance training-induced skeletal muscle hypertrophy is associated with the differential regulation of 110 non-coding RNA (ncRNA) genes, which mediate growth via specific cell types including leukocytes, satellite cells, and pericytes.

This research confirms that muscle growth is not just about mechanical tension but involves complex genetic regulation via non-coding RNAs. For the average lifter, this means individual genetic variability plays a huge role in response to training (only 61% were 'responders' in this study). While there is no direct intervention yet, this highlights that 'non-responders' may have different molecular profiles, suggesting future personalized training or nutritional strategies could be based on these biomarkers.

Achieving optimal control of multiple risk factors (lifestyle and metabolic) in type 2 diabetes can restore life expectancy to levels comparable to individuals without diabetes.

If you have type 2 diabetes, focus on controlling your risk factors (blood sugar, blood pressure, lipids, smoking, diet, and exercise). Doing so can add 6-9 years to your life compared to poor management and may even bring your life expectancy in line with someone who doesn't have diabetes.

A healthy lifestyle can compensate for suboptimal metabolic control to provide longevity benefits in type 2 diabetes.

Even if your blood sugar or other metabolic numbers aren't perfect, maintaining a healthy lifestyle (not smoking, regular exercise, healthy diet) can still add 1.5-3.4 years to your life compared to someone who has perfect numbers but an unhealthy lifestyle.

Transitioning from obesity to non-obesity, transitioning from non-obesity to obesity, or maintaining stable obesity is associated with an elevated risk of chronic kidney disease (CKD) compared to maintaining stable non-obesity.

Maintaining a stable, non-obese weight is the most protective strategy for kidney health. Both gaining weight (if you are not obese) and losing weight (if you are obese) carry higher risks than staying stable. If you are obese, aim for gradual, sustainable weight management rather than rapid loss, as rapid loss may harm kidney function. Avoid weight cycling.

Extreme weight gain (≥20 kg) and substantial weight loss (>2.5 kg) are associated with increased CKD risk, forming a J-shaped or U-shaped relationship.

Avoid both extreme weight gain and substantial weight loss. Even small gains (≥2.5 kg) can increase kidney risk, especially in young adulthood. If you are obese, avoid rapid or substantial weight loss as it may also harm kidney function. Focus on stability.

The association between weight change patterns and CKD risk is stronger in individuals under 60 years of age at baseline compared to those 60 years or older.

If you are under 60, pay close attention to your weight stability. The risk to your kidneys from weight fluctuations is higher for you than for older adults. Prioritize maintaining a stable, healthy weight.

The mortality benefits of healthful plant-based diets are more pronounced in younger adults (<65 years) and men, while the risks of unhealthful plant-based diets are significantly stronger in individuals with obesity (BMI ≥ 25 kg/m²).

If you are under 65 or have obesity, paying close attention to the quality of your plant foods (choosing whole grains over refined ones) may offer you particularly strong protection against mortality. For older adults or those with normal BMI, the benefits still exist but may be less pronounced.

The primary sources of ultra-processed food energy intake vary by age group, with alcohol and grain-based products being major contributors across all groups, while legumes, milk, and dairy products become more significant contributors as UPF consumption increases and age rises.

Identify the specific ultra-processed foods that make up the bulk of your UPF intake. For many Koreans, this includes alcohol and grain-based products. For older adults, UPFs from legumes, milk, and dairy may also be significant contributors. Targeting these specific categories for reduction or substitution may be more effective than a blanket 'no UPF' rule.

The specific repetition scheme used in Low-Load Resistance Training with Blood Flow Restriction (LL-RT with BFR) does not significantly affect muscle hypertrophy outcomes when compared to High-Load Resistance Training.

You can choose your preferred repetition scheme for BFR training (whether to failure, 15 reps, or 75 reps) without worrying about which is 'best' for muscle growth. Focus on consistency and comfort.

Using external momentum (cheat repetitions) during single-joint upper body resistance training produces muscle hypertrophy equivalent to strict form, despite significantly higher total volume load.

If you are doing single-joint exercises like bicep curls or tricep pushdowns, using controlled momentum (cheat reps) to get more reps or heavier loads will likely build muscle just as well as strict form. You don't need to fear cheat reps for hypertrophy purposes, but be aware that the extra stress goes to other muscles (like shoulders or back) and may increase injury risk over time. Use them strategically to increase volume, but prioritize strict form for joint health if you are prone to injury.

Varying proximity-to-failure (progressively decreasing RIR from 4 to 1) does not enhance short-term muscle strength or hypertrophy compared to consistently training at 1 RIR in resistance-trained individuals.

If you are an experienced lifter, you do not need to vary your proximity to failure week-to-week to get stronger or bigger. Training consistently at 1 Repetition in Reserve (RIR 1) produces the same results as a program that starts easy (RIR 4) and gets harder (RIR 1). However, the varying approach results in lower perceived exertion (RPE) during the easier weeks, which may make the training feel less stressful without sacrificing gains.

Consumption of an ultra-processed dietary pattern (80% UPFs) induces significant alterations in plasma and urine metabolomic profiles compared to an unprocessed dietary pattern, affecting pathways such as glutamate, bile acid, and fatty acid metabolism.

Even if you match the protein and carbs, eating ultra-processed foods changes your body's internal chemistry differently than whole foods. Look for changes in metabolites related to bile acids and amino acids, which may signal different metabolic stressors.

Dietary fiber intake must be accompanied by adequate water intake to prevent constipation, a common adverse event of anti-obesity medications.

When taking weight loss medications, increase your intake of fruits, vegetables, and whole grains for fiber, but you MUST drink more water. Without enough fluid, high fiber can cause constipation, which is already a common side effect of these drugs.

In patients with heart failure and reduced ejection fraction (HFrEF), a BMI greater than 27 kg/m² is associated with significantly higher risks of cardiovascular mortality, heart failure hospitalization, and composite adverse outcomes compared to a BMI of 24–27 kg/m².

If you have heart failure with reduced ejection fraction, maintaining a BMI between 24 and 27 kg/m² is associated with better survival and fewer hospitalizations than having a BMI over 27. This is especially true if your heart failure is caused by coronary artery disease (ischemic). You should discuss weight management strategies with your cardiologist, as higher BMI may increase your risk of cardiovascular death and hospitalization.

Incretin-based therapies (GLP-1RA and dual agonists) cause a mild absolute decrease in skeletal muscle mass and strength, but this is offset by a disproportionately larger loss of fat and liver mass, resulting in improved relative muscle-to-body-weight ratios and preserved or enhanced physical function.

If you are using incretin-based medications for weight loss, expect some loss of absolute muscle mass, but do not panic about 'wasting.' The medication preferentially burns fat and liver fat, which improves your muscle-to-weight ratio. Your strength and endurance often improve because you are carrying less weight. To maximize muscle retention, prioritize resistance training and adequate protein intake, as the drug itself does not protect muscle mass but does not disproportionately destroy it either.